🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/03/1986 | 4,01 | 4,10 | 4,00 | 4,07 | +1,74% | 2,48% | 6.262.848 |
| 10/03/1986 | 3,99 | 4,00 | 3,98 | 4,00 | +0,08% | 0,66% | 3.169.152 |
| 07/03/1986 | 3,92 | 4,02 | 3,92 | 4,00 | +2,20% | 2,53% | 7.160.774 |
| 06/03/1986 | 3,91 | 3,92 | 3,89 | 3,91 | +0,43% | 0,85% | 6.930.634 |
| 05/03/1986 | 3,94 | 3,94 | 3,88 | 3,89 | -1,09% | 1,52% | 6.998.544 |
| 04/03/1986 | 3,96 | 4,01 | 3,93 | 3,94 | -0,50% | 2,10% | 5.961.024 |
| 03/03/1986 | 3,96 | 3,99 | 3,94 | 3,96 | -0,91% | 1,25% | 5.764.838 |
| 28/02/1986 | 4,05 | 4,05 | 3,99 | 3,99 | -1,23% | 1,64% | 5.700.701 |
| 27/02/1986 | 3,99 | 4,11 | 3,95 | 4,04 | +1,24% | 3,91% | 8.994.355 |
| 26/02/1986 | 3,99 | 4,03 | 3,96 | 3,99 | -0,08% | 1,58% | 6.749.539 |
| 25/02/1986 | 4,00 | 4,02 | 3,97 | 4,00 | -0,33% | 1,32% | 5.214.010 |
| 24/02/1986 | 4,04 | 4,04 | 4,00 | 4,01 | -0,82% | 1,15% | 7.798.378 |
| 21/02/1986 | 4,01 | 4,04 | 3,92 | 4,04 | +1,41% | 2,97% | 13.865.040 |
| 20/02/1986 | 3,91 | 3,99 | 3,89 | 3,99 | +1,61% | 2,54% | 5.564.880 |
| 19/02/1986 | 3,90 | 3,98 | 3,89 | 3,92 | +0,51% | 2,12% | 6.560.899 |
| 18/02/1986 | 3,83 | 3,90 | 3,79 | 3,90 | +2,26% | 2,86% | 6.741.994 |
| 14/02/1986 | 3,80 | 3,83 | 3,78 | 3,82 | +0,17% | 1,22% | 9.635.731 |
| 13/02/1986 | 3,81 | 3,82 | 3,75 | 3,81 | +0,35% | 1,74% | 7.730.467 |
| 12/02/1986 | 3,80 | 3,81 | 3,78 | 3,80 | +0,00% | 0,96% | 4.168.944 |
| 11/02/1986 | 3,80 | 3,80 | 3,78 | 3,80 | +0,09% | 0,52% | 3.304.973 |
| 10/02/1986 | 3,79 | 3,80 | 3,77 | 3,79 | +0,44% | 0,70% | 3.836.938 |
| 07/02/1986 | 3,72 | 3,78 | 3,71 | 3,78 | +0,44% | 1,69% | 6.628.810 |
| 06/02/1986 | 3,78 | 3,82 | 3,75 | 3,76 | -0,70% | 1,75% | 5.512.061 |
| 05/02/1986 | 3,79 | 3,80 | 3,75 | 3,79 | -0,26% | 1,14% | 5.591.290 |
| 04/02/1986 | 3,76 | 3,80 | 3,73 | 3,80 | +1,77% | 1,93% | 8.247.341 |
| 03/02/1986 | 3,65 | 3,74 | 3,64 | 3,73 | +2,27% | 2,72% | 9.816.826 |
| 31/01/1986 | 3,59 | 3,66 | 3,59 | 3,65 | +1,66% | 1,75% | 7.364.506 |
| 30/01/1986 | 3,61 | 3,61 | 3,58 | 3,59 | -0,46% | 1,01% | 4.383.994 |
| 29/01/1986 | 3,60 | 3,64 | 3,59 | 3,60 | -0,09% | 1,29% | 5.568.653 |
| 28/01/1986 | 3,61 | 3,61 | 3,58 | 3,61 | +0,37% | 0,83% | 7.190.957 |